SEC Form 5 · accession 0001209191-16-098217
Q Therapeutics, Inc. · [NONE]
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Deborah Anne Eppstein
Director
Period of report
Dec 31, 2015
Accepted (ET)
Feb 12, 2016 · 6:02 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001366541
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common StockF1 | $0.70 | Sep 9, 2015 | A | 15,479 | A | Oct 8, 2015 | Sep 8, 2025 | Common Stock | 15,479 | 2,909,250 | D |
Explanation of responses
- F1All options were fully vested on December 31, 2015.